Role of Laghupanchmula in management of Hepatitis-B.
Phase 2
- Conditions
- Health Condition 1: K77- Liver disorders in diseases classified elsewhere
- Registration Number
- CTRI/2023/06/054153
- Lead Sponsor
- Institute Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Daignosed case of heaptitis b.
2.patients with HBV DNA quantative 500-2000 IU/ml
Exclusion Criteria
1.Patients who fail to give informed consent
2.Patient with cirrhosis, portal hypertension/ascites, and obstructive jaundice.
3.Pregnant and lactating women.
4.Patient with kidney and heart disease.
5.Patient of Diabetes and Hypertension.
6.Patient infected with Hepatitis A, C, D & Hepatitis E.
7.Mentally unstable .
[4:10 pm, 02/05/2023] Anil:
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in HBV DNA QuantativeTimepoint: 5 month
- Secondary Outcome Measures
Name Time Method Reduction in SGPT and SGOT level and Bilirubin <br/ ><br>Timepoint: 1 month